BCL2L1 and non-small cell lung carcinoma: In docetaxel-resistant NSCLC cells, the forced expression of let-7c increased the in vitro and in vivo sensitivity to docetaxel via targeting BCL-xL, which was accompanied by partial reversal of the EMT phenotype [34].